Drugs / Iron oligosaccharide
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00537186 | Jun 2007 → Jul 2008 | congestive heart failure | Pharmacosmos A/S | Completed | No outcome recorded |
| Phase 3 | NCT00536666 | May 2007 → Aug 2008 | chronic kidney disease, iron deficiency anemia | Pharmacosmos A/S | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Iron oligosaccharide | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00537186 ↗ |
| Route | Intravenous | “given either as repeated IV boluses or as total dose infusion” NCT00536666 ↗ |